{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:56:53Z","timestamp":1787313413103,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council (CSC)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Uppsala Berzelii Technology Center for Neurodiagnostics"},{"name":"Swedish Parkinson Foundation"},{"name":"Swedish Alzheimer Foundation"},{"DOI":"10.13039\/501100003792","name":"Swedish Brain Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stohne's Foundation"},{"DOI":"10.13039\/501100005701","name":"\u00c5hl\u00e9n Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005701","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011898","name":"Marianne and Marcus Wallenberg Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011898","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Lennart and Christina Kal\u00e9n"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bbrc.2015.06.154","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T09:47:34Z","timestamp":1435744054000},"page":"336-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Changes in secondary structure of \u03b1-synuclein during oligomerization induced by reactive aldehydes"],"prefix":"10.1016","volume":"464","author":[{"given":"Yixiao","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christofer","family":"Lendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"\u00d6sterlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kasrayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lannfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ingelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Nikolajeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9700-5419","authenticated-orcid":false,"given":"Joakim","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.06.154_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2015.06.154_bib2","first-page":"367","article-title":"Abnormal accumulation of NACP\/alpha-synuclein in neurodegenerative disorders","volume":"152","author":"Takeda","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2015.06.154_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2015.06.154_bib4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in\u00a0vivo and in\u00a0vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2015.06.154_bib5","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.neurobiolaging.2014.10.042","article-title":"The link between the SNCA gene and parkinsonism","volume":"36","author":"Xu","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbrc.2015.06.154_bib6","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","article-title":"Evidence for a partially folded intermediate in alpha-synuclein fibril formation","volume":"276","author":"Uversky","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.06.154_bib7","doi-asserted-by":"crossref","first-page":"43495","DOI":"10.1074\/jbc.C100551200","article-title":"Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations","volume":"276","author":"Uversky","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.06.154_bib8","doi-asserted-by":"crossref","first-page":"e1004741","DOI":"10.1371\/journal.pgen.1004741","article-title":"Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation","volume":"10","author":"Lazaro","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbrc.2015.06.154_bib9","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In\u00a0vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.06.154_bib10","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awu057","article-title":"Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in\u00a0vivo","volume":"137","author":"Rockenstein","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2015.06.154_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","article-title":"Role of oxidative stress in Parkinson's disease","volume":"22","author":"Hwang","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.bbrc.2015.06.154_bib12","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2015.06.154_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","article-title":"Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease","volume":"142","author":"Sofic","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2015.06.154_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nchembio782","article-title":"Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization","volume":"2","author":"Bosco","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbrc.2015.06.154_bib15","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","article-title":"Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease","volume":"93","author":"Yoritaka","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.06.154_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurobiolaging.2006.10.022","article-title":"Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases","volume":"29","author":"Dalfo","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbrc.2015.06.154_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(01)02514-9","article-title":"Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans","volume":"319","author":"Castellani","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2015.06.154_bib18","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1523\/JNEUROSCI.5311-12.2013","article-title":"Calcium entry and alpha-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons","volume":"33","author":"Dryanovski","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2015.06.154_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2012.11.007","article-title":"Expression of human E46K-mutated alpha-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment","volume":"240","author":"Cannon","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2015.06.154_bib20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1021\/tx050080q","article-title":"4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal","volume":"18","author":"Lin","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbrc.2015.06.154_bib21","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbrc.2008.12.005","article-title":"The lipid peroxidation metabolite 4-oxo-2-nonenal cross-links alpha-synuclein causing rapid formation of stable oligomers","volume":"378","author":"N\u00e4sstrom","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2015.06.154_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.freeradbiomed.2010.11.027","article-title":"The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of alpha-synuclein oligomers with distinct biochemical, morphological, and functional properties","volume":"50","author":"N\u00e4sstrom","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2015.06.154_bib23","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1074\/jbc.M608126200","article-title":"Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation","volume":"282","author":"Qin","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.06.154_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1089\/ars.2011.4429","article-title":"Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of alpha-synuclein","volume":"18","author":"Bae","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.bbrc.2015.06.154_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mcn.2013.01.004","article-title":"Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity","volume":"54","author":"Xiang","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbrc.2015.06.154_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2015.06.154_bib27","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1074\/jbc.275.12.8812","article-title":"Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations","volume":"275","author":"McLean","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.06.154_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2015.06.154_bib29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbrc.2015.06.154_bib30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jmb.2009.02.007","article-title":"Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner","volume":"387","author":"Pham","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2015.06.154_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jmb.2008.08.039","article-title":"Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein","volume":"383","author":"Hong","year":"2008","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2015.06.154_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/13506129.2013.835726","article-title":"Off-pathway alpha-synuclein oligomers seem to alter alpha-synuclein turnover in a cell model but lack seeding capability in\u00a0vivo","volume":"20","author":"Fagerqvist","year":"2013","journal-title":"Amyloid"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15302126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15302126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:55:17Z","timestamp":1589529317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15302126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0006291X15302126"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.154","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in secondary structure of \u03b1-synuclein during oligomerization induced by reactive aldehydes","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}